Screening of FDA-approved drugs for Myleoma

The MMRF is pleased to award David A. Frank, MD, PhD, Dana-Farber Cancer Institute; Suzanne Lentzsch, MD, PhD, University of Pittsburgh; and Aaron D. Schimmer, MD, PhD, FRCPC, Princess Margaret Hospital each with a $100,000 grant award to support the testing of existing drug libraries against known molecular targets in myeloma. Using advanced screening technologies, researchers will identify compounds from these libraries that interact with known myeloma targets -- an important first step in developing these compounds into viable treatments for patients with myeloma.